Trainer Team Introduction
Zhao Xiaoliang
Deputy Chief Physician, PhD in Medicine
Department of Lung Cancer, Tianjin Medical University Cancer Hospital
Visiting Scholar, Lombardi Comprehensive Cancer Center, Georgetown University, USA
Committee Member, Tianjin Anti-Cancer Association Lung Cancer Professional Committee
Committee Member, Tianjin Anti-Cancer Association Tumor Immunotherapy Professional Committee
Standing Committee Member, Tianjin Health Education Association Lung Tumor Special Committee
Committee Member, Tianjin Medical and Health Association Oncology Branch
As a key contributor, awarded 1 First Prize and 1 Third Prize of Tianjin Science and Technology Progress Award
Zhang Zhenfa
Chief Physician, Professor, Doctoral Supervisor
Director, Department of Lung Cancer Surgery, Tianjin Medical University Cancer Hospital
Standing Committee Member, Non-Small Cell Lung Cancer Professional Committee, Chinese Anti-Cancer Association
Chairman, Tianjin Anti-Cancer Association Lung Cancer Professional Committee
Committee Member, Thoracic Surgery Branch, Chinese Medical Doctor Association
Committee Member, Thoracoscopy Group, Thoracic and Cardiovascular Surgery Branch, Chinese Medical Association
Young Director, Chinese Anti-Cancer Association
— Advocates for 4L lymph node dissection in left lung cancer, proposing "No trachea, no Zone 4"
— Promotes esophageal mobilization for 4L lymph node dissection, published in J Clin Oncol
— Proposes "Artery First," advocating artery-centered anatomical lung segment resection
Wang Changli
Chief Physician, Professor, Doctoral Supervisor
Department of Lung Cancer, Tianjin Medical University Cancer Hospital
Director, Surgical Teaching and Research Office, Tianjin Medical University Cancer Hospital
Director, Tianjin Lung Cancer Diagnosis and Treatment Center
Deputy Editor-in-Chief, Chinese Journal of Clinical Oncology
Published over 50 SCI papers in journals including The Lancet Respiratory Medicine and Journal of Clinical Oncology
Awarded multiple prizes including Tianjin Science and Technology Progress First Prize and Chinese Anti-Cancer Association Science and Technology First Prize
Li Chenguang
Deputy Chief Physician/Associate Professor/Master's Supervisor
Department of Lung Cancer, Tianjin Medical University Cancer Hospital
Professional Member, Lung Cancer Professional Committee, Chinese Anti-Cancer Association
Committee Member, Tianjin Anti-Cancer Association Lung Cancer Professional Committee
Visiting Scholar, MD Anderson Cancer Center
Editorial Board Member, Journal of Cancer Research and Clinical Oncology and Frontiers in Artificial Intelligence
Specializes in comprehensive lung cancer treatment with surgery as the core, focusing on genomic variations in lung cancer and resistance mechanisms to targeted/immunotherapy
Yue Dongsheng
Deputy Director, Department of Lung Cancer Surgery
Chief Physician, Associate Professor, Doctoral Supervisor, UCSF Visiting Scholar
Among the First National Outstanding Young Physicians
Vice Chairman, Thoracic Surgery Committee, Chinese Research Hospital Association
Vice Chairman, Infectious Tumor Committee, Chinese Anti-Cancer Association
Vice Chairman, Lung Cancer Rehabilitation Committee, China Primary Health Care Foundation
Chairman, Tianjin Health Education Association Lung Tumor Special Committee
Standing Committee Member, Non-Small Cell Lung Cancer Committee, Chinese Anti-Cancer Association
Standing Committee Member, Non-Small Cell Lung Cancer Committee, Chinese Society of Clinical Oncology
Committee Member, Lung Cancer Committee, Oncology Branch, Chinese Medical Association